ライフサイエンスコーパス: adnexal mass

1 urgically in patients with a newly diagnosed adnexal mass.

2 118 women with malignant (60) or benign (58) adnexal mass.

3 ce to evaluate sonographically indeterminate adnexal masses.

4 (MRI), which revealed bilateral bulky solid adnexal masses.

5 MR imaging criteria for characterization of adnexal masses.

6 t frequently used to detect and characterize adnexal masses.

7 a separate validation group of 39 women with adnexal masses.

8 lly or ultrasonographically detected complex adnexal masses.

9 f the screening cohort, had an indeterminate adnexal mass (108 unilateral, 10 bilateral; mean size, 4

10 ith ovarian cancer are for the evaluation of adnexal masses and for the diagnosis and evaluation of r

11 an also be helpful in characterizing complex adnexal masses and in depicting recurrent tumor after tr

12 Forty (74%) patients had benign adnexal masses, and 14 (26%) had malignant masses; three

13 ning risk of malignancy to ovarian and other adnexal masses, and to provide a management recommendati

14 enign from malignant masses, the majority of adnexal masses are benign.

15 rian Tumor Analysis) Simple Rules classifies adnexal masses as benign, malignant, or indeterminate ba

16 B, persistent bleeding, or for evaluation of adnexal masses at the time of laparoscopy.

17 lded 54 patients with breast cancer and with adnexal masses at US and histopathologic examinations.

18 onsecutive adult patients presenting with an adnexal mass between January 1, 2012, and March 1, 2015,

19 ive women with sonographically indeterminate adnexal masses between November 2016 and December 2018.

20 set of 38 patients with surgically evaluated adnexal masses, but no hydrosalpinx, were randomly chose

21 About 90% of adnexal masses can be adequately characterized with US a

22 nts, and supports conservative management of adnexal masses classified as benign by use of ultrasound

23 more accurate and consistent evaluations of adnexal masses, especially when used by nonexpert clinic

24 rospective studies on long-term follow-up of adnexal masses exist.

25 during the first 2 years of follow-up after adnexal masses have been classified as benign by use of

26 included 4905 patients with a newly detected adnexal mass in 17 centers that met predefined data qual

27 The presence of an adnexal mass in the absence of an intrauterine pregnancy

28 independently reviewed the sonograms of 252 adnexal masses in 226 women and recorded US features by

29 lipid metabolic phenotypes in patients with adnexal masses, integrating quantitative lipidomics prof

30 differentiating between benign and malignant adnexal masses is proportional to the expertise of the o

31 mination for the exploration of an equivocal adnexal mass (January 2007 to December 2012) with surgic

32 e selected for conservative management of an adnexal mass judged to be benign on ultrasound on the ba

33 ness (LR+ 4.9; 95% CI, 1.7-14; n = 1435), an adnexal mass (LR+ 2.4; 95% CI, 1.6-3.7; n = 1378), and a

34 12) and control subjects either with benign adnexal mass (n = 5) or free from disease (n = 6).

35 pian tubes and differentiate them from other adnexal masses on the basis of morphologic features.

36 arian torsion, MR imaging demonstrated right adnexal mass or inflammation.

37 n the evaluation of the pregnant patient for adnexal masses, pelvimetry, hydroureteronephrosis of pre

38 All 11 patients with benign adnexal masses that clinically can be confused with mali

39 onsecutive patients aged 18 to 89 years with adnexal masses that were managed surgically or conservat

40 ctober 30, 2010, for characterization of 497 adnexal masses that were seen at US.

41 Thirty-six patients with 50 adnexal masses (tubo-ovarian abscess, n = 24; ovarian ma

42 cale and Doppler sonographic features of 211 adnexal masses were correlated with the final diagnosis;

43 n in discriminating endometriomas from other adnexal masses were evaluated.

44 nts aged 18 years or older with at least one adnexal mass who had been selected for surgery or conser

45 with the importance of careful reporting of adnexal masses, will also be reviewed.

46 s of adnexal torsion in patients who have an adnexal mass with acute or subacute pelvic pain.

47 An adnexal mass with diffuse low-level internal echoes and

48 malignancy and acute complications is low if adnexal masses with benign ultrasound morphology are man

49 ging features that had been recorded for the adnexal masses with each imaging modality were reviewed

50 rospective study of sonographically detected adnexal masses with known clinical outcomes from two ins

51 nhanced MR imaging depicted 176 (94%) of 187 adnexal masses, with an overall accuracy for the diagnos

52 he detection and characterization of complex adnexal masses, with excellent inter- and intraobserver